Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1321–1344 of 3,714 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Muscle Disorders Clear all

Conditions: Duchenne Muscular Dystrophy
Interventions: ELEVIDYS, Sirolimus, Glucocorticoids, Antibiotics; Drug
Lead sponsor: Sarepta Therapeutics, Inc.; Industry
Eligibility: 4 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tenosynovial Giant Cell Tumor
Interventions: Pexidartinib; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 7
States / cities: Scottsdale, Arizona • Los Angeles, California • Miami, Florida + 4 more

Conditions: Dupuytren's Contracture
Interventions: Not listed
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 7
States / cities: Phoenix, Arizona • Greenwich, Connecticut • Temple Terrace, Florida + 4 more

Conditions: Patellofemoral Pain Syndrome
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
Interventions: Intismeran autogene, BCG; Biological
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 20
States / cities: Bakersfield, California • Los Alamitos, California • Los Angeles, California + 15 more

Conditions: Parkinson's Disease
Interventions: Respiratory muscle strength training; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 45 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Fatigue, Stress, Burnout, Professional, Musculoskeletal Pain, Back Pain, Neck Pain, Headache, Dizziness, Sleep Disturbance, Chest Pain, Syncope, Cardiovascular Diseases, Shortness of Breath, Gastrointestinal Diseases
Interventions: Not listed
Lead sponsor: TMRW Life Sciences; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 246 participants
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Cerebral Palsy, Spinal Muscular Atrophy, Spinal Cord Injuries, Spina Bifida, Development Delay, Genetic Disease
Interventions: Power Wheelchair Standing Device; Device
Lead sponsor: Grand Valley State University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Chronic Pain, Musculoskeletal Pain, Musculoskeletal Pain Disorder
Interventions: Empowered Relief, Move to Health, Usual Care as determined by primary care provider; Behavioral · Other
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 5
States / cities: Fairbanks, Alaska • Schofield Barracks, Hawaii • San Antonio, Texas + 1 more

Conditions: Ewing's Sarcoma, Leukemia, Lymphoma, Brain Tumors, Rhabdomyosarcoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 2 Years to 40 Years
Enrollment: 482 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sarcopenia
Interventions: Acute Resistance Exercise; Procedure
Lead sponsor: Tufts University; Other
Eligibility: 20 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Transitional Cell Carcinoma of Bladder, Superficial Bladder Cancer
Interventions: Hyperthermia System, Mitomycin C; Device · Drug
Lead sponsor: Mark Dewhirst; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bladder Cancer, Urothelial Carcinoma
Interventions: 18F-fluciclovine, PET/CT; Drug · Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Musculoskeletal Pain
Interventions: Cannabidiol (CBD); Drug
Lead sponsor: Pure Green; Industry
Eligibility: 21 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Chadds Ford, Pennsylvania

Conditions: Muscle Synthesis
Interventions: Soy Dairy Protein Blend, Positive Control (Dairy Whey Protein); Dietary Supplement
Lead sponsor: DuPont Nutrition and Health; Industry
Eligibility: 55 Years to 70 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Bladder Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Fatigue Syndrome
Interventions: Posture Study, Autonomic Function Tests, and a Stress Test; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Non-muscle Invasive Bladder Cancer
Interventions: TARA-002; Biological
Lead sponsor: Protara Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 11
States / cities: Los Angeles, California • Jacksonville, Florida • New Orleans, Louisiana + 8 more

Conditions: Tendinopathy
Interventions: Isometric Exercise, Sham Transcutaneous Electrical Nerve Stimulation; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 15 Years to 28 Years · Male only
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Restrictive Burn Scars
Interventions: Autologous fibroblasts, placebo sterile saline; Biological
Lead sponsor: Castle Creek Biosciences, LLC.; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 9
States / cities: Sacramento, California • San Diego, California • Miami, Florida + 6 more

Conditions: Sport-related Concussion, Brain Concussion, Healthy
Interventions: high-intensity neck strengthening, Control group; Other
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years to 19 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 5 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Pain Associated With Fibromyalgia
Interventions: DS-5565, Pregabalin, Placebo tablet, Placebo capsule; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 1,293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 92
States / cities: Glendale, Arizona • Phoenix, Arizona • Anaheim, California + 89 more

Conditions: Fibromyalgia (FM)
Interventions: Low-intensity ultrasound brain stimulation, Sham (No Treatment); Device
Lead sponsor: University of Utah; Other
Eligibility: 22 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting

Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Muscle Strength Loss and Its Effect on Knee Cap Motion in Volunteers With Anterior Knee Pain

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Masked Faces in Parkinson Disease: Mechanism and Treatment

The U.S. Embryologist Fatigue Study

Pediatric Powered Wheelchair Standing Devices: An Exploratory Study

The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

Role of MicroRNAs on Age and Contraction-induced Skeletal Muscle Growth

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

Effects of Protein Blends on Muscle Protein Synthesis in Healthy Older Adults

Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer

Noradrenergic and Stress-Related Etiologies of Chronic Fatigue Syndrome

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

The Acute Effects of an Isometric Loading Intervention on Lower Extremity Landing Biomechanics in Individuals With Patellar Tendinopathy

Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars

How do the Neck Muscles Influence Head Acceleration During Sport-associated Impact Events in High School Athletes?

The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

Treatment of Pain Associated With Fibromyalgia

Personalized Ultrasonic Brain Stimulation for Fibromyalgia